Stress Biomarkers Linked to Neurocognitive Function in Young Adults at Suicide Risk

A new study is drawing attention to a question at the intersection of stress biology, brain function and suicide prevention: can biological signals of the body’s stress-response systems help explain why some young adults at risk for suicidal behavior experience changes in neurocognitive functioning over time? Published in Translational Psychiatry, the research by N. Toukhy, M. Jia-Richards, E. Goodfriend and colleagues investigates the longitudinal association between stress-response biomarkers and cognitive performance, focusing on a population whose mental-health risks may evolve during a particularly sensitive period of development.

Young adulthood is marked by major changes in education, employment, relationships, independence and identity. It is also a period when many psychiatric conditions emerge or intensify. Suicidal behavior rarely results from a single cause; instead, it can reflect the interaction of psychological distress, social adversity, genetic vulnerability, sleep disruption, substance use and biological stress responses. By examining these factors together across time, the study addresses a central challenge in modern psychiatry: identifying measurable processes that may help explain changes in risk before a crisis occurs.

The term “stress-response biomarkers” refers to biological measurements that provide clues about how the body detects and manages stress. One of the most important systems involved is the hypothalamic-pituitary-adrenal, or HPA, axis. When the brain perceives a threat, the hypothalamus signals the pituitary gland, which activates the adrenal glands to release cortisol and other hormones. This response is essential for survival, but repeated, prolonged or poorly regulated activation can influence sleep, immune activity, mood and brain function. Biomarkers related to this system may therefore offer a biological window into how chronic stress affects cognition and emotional regulation.

The study’s focus on neurocognitive functioning is equally significant. Neurocognition includes mental processes such as attention, working memory, processing speed, learning, decision-making and inhibitory control. These abilities help people evaluate consequences, shift perspective and regulate impulses, particularly during emotionally intense situations. Difficulties in these areas do not determine whether someone will engage in suicidal behavior, and they should never be treated as a standalone prediction tool. However, changes in cognitive control may affect how a person responds to overwhelming distress, interprets available choices or accesses support during a rapidly escalating crisis.

A longitudinal design allows researchers to move beyond a single snapshot. In a cross-sectional study, biomarker levels and cognitive performance are measured at one point, making it difficult to determine whether one changes before or after the other. A longitudinal investigation instead follows participants over time, repeatedly assessing biological and cognitive measures. This approach can reveal whether baseline stress-related biology is associated with later neurocognitive performance, whether cognitive functioning changes alongside biomarkers, or whether both reflect a third influence, such as depression, trauma exposure, medication use or sleep disturbance.

The wording of the study’s title is important because it refers to an “association,” not proof that stress biomarkers cause cognitive changes or suicidal behavior. Biological measurements are complex and can vary with the time of day, recent food intake, physical activity, illness, medication, menstrual-cycle factors and the immediate emotional environment. Cortisol, for example, follows a daily rhythm and may be influenced by both acute stress and long-term regulation of the HPA axis. Careful statistical modeling and repeated measurements are therefore essential when researchers attempt to distinguish a stable biological pattern from a temporary fluctuation.

The research is especially relevant because young adults at risk for suicidal behavior are not a biologically uniform group. Two individuals may report similar levels of suicidal thoughts while having very different histories of trauma, anxiety, depression, sleep problems, substance exposure or social support. Their stress systems may also respond differently to the same challenge. Some people may show heightened reactivity, while others may display a blunted or poorly timed response after prolonged stress. Studying this variation could help scientists understand why identical psychological symptoms can produce very different patterns of attention, decision-making and emotional control.

If stress-related biomarkers are consistently linked with neurocognitive changes, the findings could eventually support more individualized research and clinical monitoring. Such measures might help identify people who need closer assessment, guide studies of interventions that target stress regulation, or clarify why treatments work for some patients and not others. Possible approaches could include psychotherapy, sleep-focused care, physical-activity programs, medication, social-support interventions and techniques designed to improve emotional regulation. Yet biomarkers are not destiny, and no blood, saliva or physiological measurement can determine with certainty whether an individual will attempt suicide. Clinical judgment and direct, compassionate communication remain indispensable.

The study also highlights the promise and limitations of translational psychiatry, a field that seeks to connect biological mechanisms with real-world mental-health care. Translational research is most valuable when it avoids reducing complex human experiences to a single molecule or laboratory result. Stress biology can illuminate part of the pathway linking adversity to brain function, but it cannot capture the full influence of relationships, culture, economic insecurity, access to care or personal meaning. The strongest future research will likely combine biomarkers with repeated psychological assessments, cognitive testing, digital behavior measures and detailed information about participants’ environments.

By following the relationship between stress-response biology and neurocognitive functioning in young adults vulnerable to suicidal behavior, Toukhy, Jia-Richards, Goodfriend and their colleagues contribute to a growing effort to understand suicide risk as dynamic rather than fixed. The broader message is both scientifically ambitious and clinically cautious: the body’s response to stress may be connected to how the brain manages information and emotion, but that connection must be studied over time and interpreted within the person’s life context. As researchers continue to map these pathways, the ultimate goal is not to label individuals by biology, but to detect suffering earlier and expand opportunities for effective, timely support.